New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA
08 oct. 2024 07h30 HE
|
Biogen Inc.
Findings from Part B and Part C of the DEVOTE study support the clinical benefits of a higher dose regimen of nusinersen (50/28 mg) in both individuals previously treated and treatment-naïve to...
Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA
04 sept. 2024 07h30 HE
|
Biogen Inc.
Positive study demonstrates the potential for investigational higher dose nusinersen regimen to advance the treatment of SMA; Biogen plans to submit for regulatory approval of this investigational...
Trexo Robotics Partners with KidsPhysio to Enhance Access to Innovative Physiotherapy Solutions for Children
23 mai 2024 08h47 HE
|
Trexo Robotics
KidsPhysio is hosting Trexo Robotics full day Roadshow in Surrey, BC on Saturday May 25th. Kiddos can trial Trexo Robot Legs and talk to the Trexo team
Stable Connections Hosts Trexo for a Groundbreaking Day of Robotic Leg Trials in Winnipeg, Manitoba
18 mai 2024 05h57 HE
|
Trexo Robotics
Trexo Robotics first ever Canadian Roadshow hosted by Stable Connections in Winnipeg. Kiddos will have the opportunity to trial Trexo robotic legs.
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
06 mars 2024 07h30 HE
|
Biogen Inc.
New data from the RESPOND study show that neurofilament levels, an indicator of neurodegeneration, were reduced in nearly all study participants treated with SPINRAZAReductions in biomarker complement...
Neurological Biomarkers Market Worth $14.45 Billion by 2027 – Comprehensive Report by The Insight Partners
30 oct. 2023 07h32 HE
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Biomarkers are the molecules that indicate the presence of a disease. The biomarkers of the neurological disorders were not that accessible in earlier...
Newborn Screening Market Worth $2.48 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
09 oct. 2023 08h45 HE
|
The Insight Partners
Pune, India, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Newborn screening involves testing a newborn for serious medical conditions and certain harmful or potentially fatal disorders that are not apparent at...
Camelot Portfolios Announces Cash Alternatives and Hedging Strategies
30 mars 2023 15h19 HE
|
Camelot Portfolios LLC
MAUMEE, Ohio, March 30, 2023 (GLOBE NEWSWIRE) -- Camelot Portfolios today announces an expanded lineup of cash alternatives and hedging strategies to help Investment Advisors serve clients seeking...
Robotic Legs Will Help Children Walk for the First Time at Toronto Area Facility
12 juil. 2022 14h00 HE
|
Trexo Robotics
TORONTO, July 12, 2022 (GLOBE NEWSWIRE) -- Thanks to an outpouring of community support, Kayla’s Children Centre won Trexo Robotics’ Canada- wide Trexo Plus Robotic Gait Trainer Giveaway. ...
Enhanced Profiles Drive BlackRock, Invesco and Boutique Managers to The Wealth Advisor's New Model Portfolio Selection Guide
22 oct. 2021 14h03 HE
|
The Wealth Advisor
SANTA MONICA, Calif., Oct. 22, 2021 (GLOBE NEWSWIRE) -- The Wealth Advisor, a Marina Media LLC publication, today announced the upcoming launch of the first Model Portfolio & SMA Strategists:...